Sargent Investment Group »

Summit Therapeutics shares owned by Sargent Investment Group

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Sargent Investment Group from 13F filings

Historical chart of Sargent Investment Group investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Sargent Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Sargent Investment Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $41k 10k 4.14
2023-12-31 $26k 10k 2.61
2023-09-30 $19k 10k 1.87
2023-06-30 $25k 10k 2.51